UAB News Eligible patients should currently be using metformin, a sulfonylurea , or a combination of both, but unable to achieve adequate glycemic control. More information about the ENDO Trial can be found at www.endobarriertrial.com or by calling 1-888-9STUDY9 ...
Xconomy GI is enrolling patients between the ages of 21 and 65 who have a body mass index of between 30 and 50, have uncontrolled type 2 diabetes, and currently use either metformin or sulfonylurea or a combination of the two but can't keep their blood sugar ... and more »
PR Newswire (press release) RIDGEFIELD, Conn. and INDIANAPOLIS, June 22, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE:...
FarmersWeekly Where straight sulfonylurea only have been used, there are no establishment issue for following rape or beans. A dry, late spring/summer could cause issues to arise with following crops where growers have applied Lexus (flupyrsulfuron) in autumn 2012 ... and more »
PMLiVE A randomised, double-blind, placebo-controlled study with a 24-week treatment period, GetGoal-L-Asia assessed Lyxumia's safety and efficacy in patients who whose type 2 diabetes was insufficiently controlled with basal insulin with or without sulfonylurea .
Family Practice News Digital Network ... participated in four separate randomized, placebo-controlled, phase III trials in which empagliflozin at 10 or 25 mg/day was given as monotherapy or as an add-on to either metformin, metformin plus a sulfonylurea , or pioglitazone with or without ... and more »
MedPage Today However, mild hypoglycemic events occurred more often with those on salsalate (41 patients versus 23 patients, P=0.036), and there was a six-fold increased relative risk of mild hypoglycemia when salsalate was added to sulfonylurea (P ... and more »
HealthCanal.com Eligible patients should currently be using metformin, a sulfonylurea , or a combination of both, but unable to achieve adequate glycemic control. More information about the ENDO Trial can be found at www.endobarriertrial.com or by calling 1-888-9STUDY9 ... and more »
UPI.com The standard regimen begins with a single agent -- metformin, adds another -- sulfonylurea -- when the first agent fails, and then adds insulin injections as needed to control blood glucose after the second agent fails. DeFronzo reported mean ...
News-Medical.net Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc pooled analysis showing patients with type 2 diabetes and mild renal impairment treated with JANUVIA- (sitagliptin) 100 mg once-daily ...
